SEE FAR CBT for Adults With PTSD
Official title: A Clinical Study Evaluating the Effects of a SEE FAR CBT Intervention on Psychological Outcomes in Adults With Posttraumatic Stress Disorder.
Run by Community Stress Prevention Center · NCT07720674 · Data updated 2026-11-12
This 12-week, one-on-one SEE FAR CBT program tests a trauma-focused therapy to see if PTSD symptoms improve in adults 18 and older.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Community Stress Prevention Center Academic / other |
| Locations | 1 site (Kiryat Shmona) |
| Status | Recruiting |
| Started | July 2026 |
| Main results expected | December 2027 |
| Study ends | March 2028 |
| Registry record updated | July 22, 2026 |
| Trial ID | NCT07720674 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years and older with PTSD symptoms (PCL-5 score ≥ 30) who can commit to 12 weekly sessions and complete all study questionnaires.
✕Probably not a fit
Individuals with PTSD who do not respond to SEE FAR CBT or who have conditions preventing full participation may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study uses a single-arm design to deliver SEE FAR CBT over 12 weekly sessions to adults with PTSD. Participants complete self-report questionnaires at baseline, after the intervention, and at a 3-month follow-up to track changes in PTSD symptoms and related psychological outcomes. The study aims to observe how PTSD symptoms evolve during treatment and afterward in a real-world clinical setting. Eligible participants are adults with a PCL-5 score of 30 or higher and who can commit to all study visits and consent procedures. Exclusion criteria include current pregnancy, recent psychotherapy initiation within the last 3 months, or recent initiation of psychiatric medication within 3 months.
Why it matters
Potential benefit: If successful, participants could experience reductions in PTSD symptoms and improvements in related psychological outcomes after completing SEE FAR CBT.
How similar studies have gone: Previous research on trauma-focused CBT approaches in PTSD has shown benefit; this study tests SEE FAR CBT in a single-arm format to establish feasibility and signal of effect.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria Participants must meet all of the following criteria: * Age 18 years or older * PTSD symptoms, defined as a PCL-5 score of 30 or above * Able to provide informed consent * Willing and able to participate in 12 weekly individual therapy sessions and complete study questionnaires at baseline, post-intervention, and 3-month follow-up Exclusion Criteria Participants will be excluded if they meet any of the following criteria: * Pregnancy at the time of enrollment, due to the potential influence of pregnancy and childbirth during the treatment or follow-up period on psychological outcomes. * Currently receiving psychotherapy of any type that began less than 3 months prior to enrolment. * Initiation of psychiatric medication less than 3 months prior to enrolment.
Where it's running
-
Community Stress Prevention Center
Kiryat Shmona, Israel Recruiting
Study contacts
- Principal investigator: Meital Mashash, PhD — Community Stress Prevention Center
- Study coordinator: Meital Mashash, PhD
- Email: meitalm@icspc.org
- Phone: 972-50-2888052
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Anger, Social Thinking, and PTSD in French Veterans
This study tests whether PTSD in former French military personnel is linked to higher anger through changes in social thinking abilities.
-
TSND-201 treatment for PTSD in adults
This study tests two doses of TSND-201 or placebo to see if it helps adults with PTSD.
-
Long-term outcomes after Hyperbaric Oxygen Therapy in veterans with TBI, PCS, or PTSD
This study tests whether benefits from HBOT persist over time for veterans with brain injury or related conditions.
-
Brief SEE FAR CBT: a short, focused therapy for adults with PTSD
A 6-session Brief SEE FAR CBT treatment is tested against usual dynamic psychotherapy for adults with PTSD to see if it reduces symptoms.
-
MDMA Therapy for PTSD in Veterans
This phase 2 study tests a fixed 120 mg dose of MDMA, followed by a 60 mg supplemental dose, plus therapy, to see if it helps adults who are veterans with PTSD.
-
Predicting childbirth PTSD after unplanned cesarean using early postpartum screening
This study tests whether brief postpartum questionnaires taken 24-48 hours after delivery can predict childbirth-related PTSD symptoms at 6 weeks in people who had an unplanned cesarean.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.